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All cancers must maintain their chromosomal ends (telomeres) in order to continue to proliferate 
indefinitely and to prevent intolerable levels of chromosomal instability. In ~95% of cancers, telomeres 
are maintained, or extended, through the reactivation of the telomerase enzyme. For the remaining 5% 
of cancers, a homologous recombination-dependent mechanism called alternative lengthening of 
telomeres (ALT) is utilized. ALT has several associated characteristics, but no one biomarker is defining. 
It becomes necessary then to examine a body of data on the presence of these characteristics to confirm 
a cancer as having ALT as a telomere maintenance mechanism (TMM). One such characteristic is the 
presence of large ultra-bright telomere DNA foci visible by fluorescence in situ hybridization (FISH), and 
the co-localization of these foci with immunoaffinity signals for the promyelocytic leukemia protein 
(PML) which together are referred to as ALT associated PML bodies (APBs). Repeated reports of this 
phenomenon in the literature, coupled with experiments demonstrating that large ultra-bright telomere 
FISH foci are a likely site of significant ALT-associated activity have elevated the level of interest in APBs. 
The body of work described in this thesis addresses the question of whether PML is required for the ALT 
mechanism and the related question if the presence of APBs is a defining ALT characteristic. 
CRISPR/Cas9 was used to generate PML knockouts in the ALT-positive human cancer-derived cell lines 
U2OS and SAOS2. Cell viability and maintenance of telomeres over long term culture, the presence of 
telomere DNA c-circles, homologous recombination at telomeres, and the absence of telomerase 
activity were all tested. The results were consistent with ALT representing a TMM in PML-knockout 
U2OS and SAOS2 cells. Large telomere ultra-bright foci still formed in cells lacking PML, and were found 
to co-localize with the APB components SP100 and DAXX. However, the extent to which SP100, DAXX 
and large telomere foci co-localized relative to the total number nuclear bodies formed by each of these 
proteins was found to be significantly reduced. Therefore, while it is not required for ALT, PML does 
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significantly impact the frequency of co-localization between SP100, DAXX and large telomere foci, 
which suggests that the function of PML in ALT is as a mediator of nuclear trafficking at APBs.  
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Part 1 Telomere   
In humans, the sequence of a linear chromosome begins with the nucleotides TTAGGG and ends 
with CCCTAA. These complementary sequences exist at the termini as a hexanucleotide repeat of 
approximately 10 kb in length, on average. [1] The function of the telomere is to protect the end of the 
chromosome from degradation and prevent the recognition of the end of the chromosome as a DNA 
double strand break. [2] Chromosomes are not blunt ended. There is, in mammals, a single stranded 
length of the 3’ TTAGGG repeats that is between 50 and 200 nucleotides long. [3] This is referred to as 
the 3’ overhang. Electron microscopy of mammalian telomeres has shown the presence of a duplexed 
lariat structure at telomere ends. [4] These are referred to as telomere-loops (T-loops). [5] They form as 
a result of strand invasion of the 3’ overhang to a site in cis of the telomere. Formation of the loop acts 
to sequester the end of the chromosome. [6]  
Telomere sequences are complexed to the six proteins of shelterin. The shelterin complex is 
bound along the length of the telomere as a repeating unit of the six proteins, and is composed of the 
proteins TRF1, TRF2, RAP1, POT1, TIN2, TPP1. [2] Shelterin contributes to the chromosome end 
protection function of the telomere. The TRF1 and TRF2 components confer telomere repeat sequence 
binding affinity. [7, 8] Occupation of the telomere repeats sequesters the sequence from other 
nucleoplasmic proteins. Experimental inactivation of TRF1 causes gaps in telomere DNA and robust 
activation of the DNA damage response pathway (DDR). [9] [10] Likewise, TRF2 also suppresses the DDR 
pathway by inhibiting the DNA double-strand break sensor protein ATM. Experimental deletion of TRF2 
can result in multiple chromosomes fusing together at their telomeres.[11-13] RAP1 deletion can cause 
increased telomere recombination and fragility.[14]The shelterin proteins also have a demonstrated 
function in assembly of the architecture of the telomere.  POT1 is responsible for the binding and 
creation of the T-Loop.[15] TPP1 cooperates with POT1 and acts as a shelterin organizing center.[16-18]  
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A long non coding RNA referred to as TERRA (telomere repeat RNA) binds TRF2 and is 
considered a part of the shelterin complex.[19] TERRA is the product of the transcription of the C strand 
of telomeres.[20] There is no detectable transcription from the telomeric G strand, as assessed by QPCR 
and Northern blotting. TERRA is, on average, 300bp but can range from 100 bp to over 1 kb. [21] 
Transcription of TERRA is carried out by RNA pol II and begins in the subtelomeric region and proceeds 
into the telomere sequence. Within the subtelomeric region, a sequence of bases occurring as a 
repeating pattern of 61 bases, followed by 29 bases, followed by 37 bases, were identified as a TERRA 
promoter sequence.[22] Since it is made up of G-rich telomere repeats, TERRA can potentially form G-
quadruplexes. [23] TERRA is critical for stability of the shelterin complex, with its knockdown leading to 
DNA damage responses, senescence, and telomere shortening - which is typical of experiments where 
shelterin components are disrupted.[20, 24, 25] It also plays a role in the replication of telomeres by 
cooperating with hnRPA1 to regulate the RPA to POT1 switch.[26] Furthermore, TERRA promotes 
heterochromatin formation through recruitment of HP1a to telomeres.[19] TERRA is produced 
throughout the cell cycle, but its abundance peaks at the start of S phase and is at a nadir at the start of 
G2.[21, 27]  
Dividing human somatic cells have steadily decreasing telomere lengths over time. [28] The 
biochemical explanation for this phenomenon is referred to as the “end-replication problem”, as shown 
in figure S1-1 [29]. DNA polymerases require a 3’ hydroxyl group on the deoxyribose ring of DNA for the 
catalysis of the phosphodiester linkage between two adjacent nucleotides. DNA polymerases therefore 
cannot synthesize entirely new strands without a 3’ hydroxyl for use as a primer. This hydroxyl is 
supplied by a short RNA primer sequence bound to, and transcribed from, the template strand being 
replicated. In the so-called lagging strand, the primer is later degraded and replaced by DNA 
polymerized from an upstream DNA fragment (Okazaki fragment). (figure S1-1) At the 3’ overhang a 
short complementary RNA primer can be generated. Due to this primer sequence being at the terminus 
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of the chromosome when the primer is degraded the sequence cannot be replaced through extension of 
an adjacent Okazaki fragment. This results in a shortened 5’ strand. The solution for the maintenance of 
telomere lengths in humans is the reverse transcriptase enzyme telomerase.[30-33]   
Telomerase, a ribonucleoprotein reverse-transcriptase, can add telomere repeats de novo to the 
3’ end of the chromosome. Telomerase is composed of two parts, the protein component TERT, and the 
RNA component TERC. A single telomere repeat is present in TERC at the active site of TERT. TERC acts 
as a template for base addition. Study of telomerase activity indicates that addition occurs in 6 bp single 
telomere repeat intervals.[34] The extension of the available template for the 5’ strand compensates for 
the loss of the sequence due to the end replication problem. (figure S1-1) Human stem cell 
compartments require telomerase to replenish their telomeres. Patients with defective components of 
the telomerase pathway have pathologies relating to stem cell failure. Bone marrow failure, pulmonary 
fibrosis, and increased age-related diseases are all known consequences of telomerase dysfunction.[30, 
35, 36] In contrast to stem cells, most human somatic cells do not express telomerase. [37] 
The Hayflick limit describes the growth of human somatic cells over time in tissue culture 
settings. [38] As these cells undergo rounds of replication, they will eventually enter senescence and fail 
to divide further. Research suggests that this limit is connected to the progressive telomere shortening 
that occurs during every replication cycle. [28, 34] Human cancer cell lines are not subject to the Hayflick 
limit, and are  capable of presumably indefinite replication cycles. For a cancer to accomplish indefinite 
replication they must have an active telomere maintenance mechanism (TMM).  In approximately 95% 
of cancers, telomerase expression is activated.[39] Examples of changes to cancer cells that serve to 
activate telomerase expression include, but are not limited to, changes in telomerase gene methylation 
status, genomic translocations of the telomerase gene or, modifications in transcriptional networks 
regulating telomerase expression.[40-45]  It is important to note that telomerase activity is measurable 
but the protein itself is not. It is thought that there are fewer than 100-200 telomerase complexes in a 
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cancer cell. At these levels, telomerase is generally not detectable by immunohistochemistry or western 
blot.[32, 33]   
Part 2 Alternative lengthening of telomeres  
If a cancer cell line or tumor isolated from a patient has a TMM but no telomerase activity, it is 
designated as containing an alternate lengthening of telomeres (ALT) pathway. These samples are 
designated as ALT positive (+) cells. At present, the literature states that approximately 5% of cancers 
utilize ALT.[46-50] Initial discovery of ALT was suspect due to the fact that the concept of telomerase 
was still fairly new and it is difficult to measure telomerase activity, thus false negative assay results 
were a distinct possibility. [51, 52] Over time however, a body of convincing evidence was established in 
support of ALT as a bona fide TMM.[39, 46, 50, 53-58] This work established characteristics associated 
with ALT (+) cells, some of which are now considered ALT biomarkers. 
First and foremost a cell line designated as ALT (+) must be able to be passaged (grown) 
continually, long-term, without undergoing replicative senescence. During this time, these cells also 
must maintain their telomere lengths through replication cycles. This is established by analyzing the cell 
line’s telomere lengths at time points of low and high number of population doublings.[51, 52] Telomere 
lengths and their distribution are measurable by the terminal restriction fragment assay (TRF).[59] This 
assay relies on the fact that there are no restriction enzyme sites in telomere sequences. Thus, when 
genomic DNA is isolated and cut with a high cutting frequency restriction enzyme, the only large 
segments of DNA remaining should be the telomeres. Separation of these lengths on an agarose gel 
followed by Southern blotting with a telomere sequence probe allows for TRF analysis.[52, 59]   
Continuous growth and constant telomere lengths implies circumvention of the Hayflick limit and the 
presence of a TMM. These passages must also be negative for telomerase activity.[39, 53, 56, 60]  
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Telomerase activity is measurable by the telomere repeat amplification protocol (TRAP).[61] In 
TRAP, cell lysates are incubated with a suitable DNA substrate for telomerase elongation activity;  
yielding a laddering of the aforementioned 6 bp telomere repeats if telomerase is active. Visualization of 
the elongated substrates is carried out by first amplifying the elongation products with the polymerase 
chain reaction, followed by acrylamide gel electrophoresis separation of the PCR products. No laddering 
implies no telomerase activity.[61] Prolonged continuous growth in vivo, having a TMM, and lack of 
telomerase activity represent the essential requirements for defining a cell line as ALT(+).[51, 52, 62, 63] 
Beyond this requirement there are other ALT associated characteristics described below. In lieu of the 
aforementioned in vivo requirements, these associated characteristics (biomarkers) are used to support 
the designation of a sample as ALT (+), (e.g. when live cells are not available) and also provide potential 
clues to the mechanism of the ALT pathway. 
ALT(+) cells have been recorded as having homologous recombination (HR) events at their 
telomeres, events that are absent at telomeres of ALT(-) cells. Telomeric HR events are measurable by 
the chromosome in situ hybridization (CO-FISH) assay.[53] [63 ]This assay is outlined in figure S2-1.  In 
addition, homologous recombination at telomeres was identified by an experiment in which a tagged 
sequence cassette was inserted in one of the telomeres of an ALT utilizing line.[63] The cassette could 
be tracked using PCR and southern blotting and over time the cassette spread to other telomeres of the 
cell. Knockdown of components of homologous recombination, such as the MRE11/NBS1/RAD50 
complex, cause senescence and apoptosis in ALT(+) cells, implicate DNA damage signaling  and 
homologous recombination as important for the continued replication of ALT(+) cells.[55, 64, 65] These 
publications contribute to the current understanding of the mechanism of the ALT pathway to be based 
on homologous recombination. The overall telomere lengths in an ALT cell line as measured by Southern 
blotting are extremely heterogeneous, typically ranging from below 1 kb to above 10 kb. [56] Unequal 
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recombination events leading to one telomere being extended while another is shortened may be 
contributing to the source of this heterogeneity. 
The presence of extrachromosomal circles of telomere DNA is another biomarker of ALT (+) cells 
and their formation may be linked to ongoing homologous recombination at telomeres. [66] Because 
the telomere sequence is repetitive, and therefore homologous along its length, intra-telomere 
recombination can occur which can result in the excision of a circle of telomere DNA, a schematic of 
which is provided in figure S2-2. [67] A circle of telomere C strand DNA is aptly referred to as a C-circle. 
The assay for the presence of C-circles is outlined in figure S2-3. [66] The C-circle assay utilizes the phi29 
processive polymerase. This polymerase will continuously polymerize if template is available and is 
capable of DNA strand displacement. Research suggests that at least a fraction of C-circles are partially 
double stranded.[66, 68] Thus, fragments of G rich telomere DNA strands are hybridized to the 
covalently linked circle of C rich telomere standand can therefore serve as  a primer for DNA 
polymerization by phi29 polymerase. Because the template is circular, phi29 can continuously 
polymerize. What results is significant amounts of DNA complementary to the C-circle. The products can 
then be dot blotted onto a membrane and visualized by hybridizing a labelled G-rich telomere sequence 
probe to the membrane. A sample is considered positive for c-circles if any signal is detected from this 
reaction, thus the c-circle assay is used as a binary marker for ALT-positivity.[66] 
ALT (+) cells contain a nuclear structure referred to as an ALT associated promyelocytic leukemia 
protein (PML) body (APB). These are PML nuclear bodies with telomere coincidence that may also 
include other ALT associated contents such as the components of the homologous recombination repair 
pathway.[54, 69, 70] Determination of the presence of APBs in whole cells on a microscope slide is 
carried out by combined fluorescent in situ hybridization (FISH) using a telomere sequence specific 
fluorescently labelled probe and immunofluorescence (IF) for the PML protein. Telomere signals co-
localizing with signals from PML are, in combination, considered APBs. The other protein contents of 
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APBs are determined through a similar co-localization analysis utilizing IF. It is not that PML forming a 
nuclear body is specific to ALT, but rather the ALT specific contents of these bodies that links PML to 
ALT. PML readily forms nuclear bodies in ALT negative cells.[71-78] The next section provides an in 
depth look at PML, followed by further explanation of the potential role of PML in ALT. 
Part 3 The Promyelocytic Leukemia Protein 
  The promyelocytic leukemia protein was initially discovered as a protein that is overexpressed in 
promyelocytic leukemia as a product of a recurrent 15;17 translocation. Here, PML is the N-terminal half 
of the oncogenic fusion protein PML-RARa; the C-terminus encodes the retinoic acid receptor.  The PML 
promoter is constitutive, so it drives high levels of the fusion protein, which acts as a dominant negative 
in this leukemia. The primary driver of the disease is the retinoic acid receptor because it has lost the 
regulatory domains of the N-terminus. [79-82] Interestingly, at first because of this association, PML was 
thought of as an oncoprotein. [83] It would only later be identified as a tumor suppressor through over 
expression studies and animal models.[72, 84] 
The PML protein has eleven recorded isoforms of varying sizes from 48 kDa to 91 kDa .[85] 
When it is assayed by western blotting, a ladder of these different isoforms is observed. PML is a 
member of the tripartite motif protein family (TRIM), comprised of a RING-B-Box-Coiled-coil (RBCC) 
domain in exons 1-3 and a SIM (SUMO interacting motif) in exon 7 (see figure S3-1). [75, 86] PML is 
mostly a nuclear protein but isoform 1 does have a nuclear export signal which allows this isoform to 
shuttle from the nucleus to the cytoplasm and back.[87] PML was present in the ancestor of all 
chordates and is expressed in all human cells. The function of PML is partly connected to its structural 
roles in the nucleus.[88]  
PML will oligomerize into hollow spheres that can be of many sizes. These spheres, referred to 
as PML nuclear bodies (PML-NB), are dynamic and change based on stress, position in the cell cycle, 
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DNA damage and differentiation status.[74, 76, 83, 89-94] The PML-NB is often described as a storage 
depot of nuclear proteins. Examples of PML body resident proteins include SP100, DAXX, ATRX and BLM. 
The PML-NB may be considered as a storage depot because DNA is not often found within the sphere, 
and it is believed PML exerts its role mostly through protein-protein interactions.[73, 95]. The functions 
of the example PML body resident proteins, on the other hand, have so far been identified as occurring 
at or with DNA sequences.[46, 94, 96-98] PML therefore may sequester these proteins from the DNA 
until their appropriate time and place of action.   
It is as a result of the diversity of potential interactions that research on the precise function of 
PML has proven challenging. Often when investigating the existing published literature on PML, one 
finds research on one of the PML interacting proteins, with an enzymatic or DNA binding domain of the 
interacting protein being the primary focus and its subsequent connection to PML although being 
secondary, heavily referenced in terms of the function of PML. Exemplifying this difficulty is the fact the 
PML knockout mouse has no gross phenotype. PML connects with many proteins but apparently itself is 
not vital in mice.[71, 72] It is of note that the database Online Mendelian Inheritance of Man (OMIM) 
lists no human genetic diseases directly linked to mutations only in the PML gene.[99]  However, PML is 
essential for induced pluripotent stem cell differentiation of human cells.[78] It is important to bear in 
mind that PML sits within a large web of interactions with no immediate discernable consequence to its 
total loss based on prior data. This fact alone makes PML an attractive target for further basic research. 
PML has mostly been studied in terms of the PML-RARa oncofusion; while exploration of its intimate 
connection to the ALT pathway has been comparatively under explored.  
The ALT associated PML body or APB is widely considered to be one of the defining features of 
ALT. APBs were discovered early in the history of ALT in 1999, while ALT had first been described as such 
in 1997. The connection between the two was made as a result of the striking uniqueness of the IF for 
TRF1 and telomere FISH stains of ALT cells.[69] Together they form a ring or a disc. This disc is, as one 
9 
 
could imagine, the cross section of a sphere observed in cut tissue sections. PML was previously 
recorded as forming this unique shape in PML bodies. When co-staining, these rings were found to be 
are coincident between all three of these protein species. These overlying rings of telomere, TRF1, and 
PML are only found in telomerase-negative cells. Through later work, the ALT specific components of 
APBs were determined to be the coincidence of telomere DNA, shelterin components and components 
of the homologous recombination repair pathway, including Rad51, BRCA1/2, BLM, WRN, 
MRE11/NBS1/RAD50. [54, 55, 69, 100-103] Interestingly, a full study of ALT cell lines characterizing APB 
prevalence has not been performed. Each cell line or patient sample will have a unique APB pattern. 
Such variation makes it challenging to make broad statements about APB frequency and its potential 
significance to ALT. Most will simply define an APB as any coincident telomere and PML focus.[101] A 
subset of cells within an ALT-positive population is typically seen to harbor relatively large amounts of 
telomere DNA sequences in discrete intra-nuclear foci. These large aggregates of telomere DNA often, 
though not always, co-localize with PML protein.  It is also possible to have large telomeric FISH foci and 
have no PML co-localization.[50]  
The functional significance of APBs to the ALT pathway may involve the purported designation 
of the APB as the site of the homologous recombination underlying the mechanism of ALT.[54, 64, 65, 
70, 101-107]  The APB is extremely unusual. The telomere signal found at APBs can be much more 
intense than a single chromosomal telomere. This could mean that it represents either the association 
of many telomeres, or a concentration of continuously replicating extra-chromosomal telomere DNA 
sequences. This replication could be the result of dysfunctional S-phase, ongoing homologous 
recombination or another repair process, and a variety of extra-chromosomal telomere DNA species 
have been identified in ALT-positive cells..  It has been reported that APBs form during G2.[54] That 
indicates this is a post-replicative process, and since homologous recombination is supposed to occur in 
G2 it lends credence to the possibility that the APB is the site of telomere homologous recombination 
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(HR). This is further supported by the presence of many HR proteins at APBs. RAD51, RAD52, RPA, 
RAD51D, BLM, WRN, RAP1, BRCA1, MRN complex and many others have been identified.[54, 57, 58, 69, 
108] These coincidences have been supported by the live cell imaging of ALT telomeres which were 
shown to cluster to APBs once damaged.[64, 101, 103, 104, 106] These same references support the 
proposal that the APB is the site of the HR believed to be the basis of the ALT pathway.  
In order to determine if there are direct requirements between the presence of the PML protein 
and the mechanism of the ALT pathway, the CRISPR/Cas9 genome editing system was used to introduce 
nonsense mutations into the PML gene of the well-characterized ALT (+) human cell lines U2OS and 
SAOS2. Long-term viability of these cell lines without the PML protein indicates that PML is not required 
for these cell lines to survive. This fact alone does not establish that ALT as a TMM is ongoing in these 
PML knockout (KO) cell lines. As outlined in part 2, each of the characteristics of ALT as a TMM must be 
assessed by their designated assays in order to provide a rigorous and informed designation of ongoing 
ALT. Once ALT status has been established as ongoing, the impact of PML KO on the number and 
frequency of co-localization of the PML body resident proteins SP100 and DAXX was assessed by IF. A 
change in the number of nuclear bodies formed by SP100 and DAXX was contradictory between the two 
cell lines; however, the frequency of co-localizations between the two proteins was decreased in both 
lines. Both SP100 and DAXX are found with telomere DNA foci in APBs. The analysis of nuclear bodies in 
PML KO cells was therefore extended to also include the ultra- bright telomere signals also found in 
APBs. Study of these three bodies provides insight into APB formation in the absence of PML. It was 
found that co-localizations between these three entities were decreased. This implies that the function 





Materials and Methods 
Cell Culture, Plasmids and transfection 
The following cell lines used in this study were obtained from American Type Culture Collection, 
Manassas, VA: U-2 OS (HTB-96), Saos-2 (HTB-85), SJSA-1 (CRL-2098), MG-63 (CRL-1427). HEK293T 
packaging line was provided by the laboratory of William Nelson (Johns Hopkins School of Medicine, 
Baltimore MD). U-2 OS, Saos-2, HEK293T were maintained in DMEM, high glucose, pyruvate 
supplemented with 10% fetal bovine serum (FBS) and 100 units/ml penicillin and 100ug/ml streptomycin 
(ThermoFischer, Waltham, MA). SJSA-1 was maintained with RPMI supplemented with 10% FBS 100 
units/ml penicillin and 100ug/ml streptomycin (ThermoFischer, Waltham, MA). MG-63 was maintained 
with MEM supplemented with 10% FBS 100 units/ml penicillin and 100ug/ml streptomycin 
(ThermoFischer, Waltham, MA). All cell lines were maintained at 37oC and 5% CO2. The following 
plasmids were obtained from Addgene Cambridge, MA: pSpCas9(BB)-2A-GFP PX458 (#48138), 
lentiCRISPRv2 (#52961), psPAX2 ( #12260), pCMV-VSV-G (# 8454), pLJMI-EGFP (#19319), pLPC-Flag-PML-
IV (# 62804), pDsRed2-N1 (#54493). The HR and NHEJ reporters were a kind gift of Vera Gubernova 
(University of Rochester, NY)[109]. The FLAG-PML gene from pLPC-Flag-PML-IV was cloned into 
pcDNA3.1 (ThermoFischer Waltham, MA). Transfections were carried out with cationic liposomes 
(Lipofectamine 3000 #L3000001, Thermo Fischer, Waltham, MA) 
Genome Editing by CRISPR/Cas9 
A wild type cas9 based genome editing strategy was devised for the PML gene. All known 
isoforms of PML have an identical N-terminus diverging at the fourth exon, thus in order to ablate all 
isoforms a target site for the second exon was designed using CRISPRdirect (http://crispr.dbcls.jp/). 
Guide RNAs were synthesized by Integrated DNA Technologies (Coralville, IA) gPML340 5’- 
CGAAGCTGCTGCCTTGTCT- 3’. Two CRISPR delivery methods were utilized. The first utilized transfection 
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to deliver pSpCas9(BB)-2A-GFP, with the above guide sequences inserted, to the U2OS cell line. A cell 
sorting procedure based on GFP was then used to isolate transfectants. Cells were plated onto 150 mm2 
round dishes. Once clonal colonies reached at least 3 mm in diameter they were isolated with cloning 
cylinders and re-plated into individual wells of a 24-well plate. Clones were screened for loss of PML 
expression via immunofluorescence (IF) and western blotting.  The second method utilized lentiviral 
delivery of lentiCRISPRv2 with the above inserted guide sequences. The remaining cell lines proved 
difficult to transfect and necessitated a lentiviral approach. Virus was produced in the HEK293T 
packaging cell line by transient transfection with the plasmids psPAX2, pCMV-VSV-G, and 
lentiCRISPRv2(PML). The supernatant from three days post transfection was used for transduction with 
8 ug/ml hexadimethrine bromide. Transduction was carried out with enough of this supernatant such 
that 10% of transduced cells were positive for inserted cas9 expression. Transduced cells were placed 
under 2 ug/ml puromycin selection three days post transduction. Colonies were picked and clones 
initially screened for loss of PML expression via IF. In order to confirm genetic disruption clones were 
sequenced at the cas9 target site through a two-step process. First PCR was performed on genomic DNA 
isolated from clones with primers flanking the cas9 target genome site. Forward: 
CGAAGCTGCTGCCTTGTCT Reverse: CTCGTGCTTGAGGAACCACT. Then PCR products were TOPO cloned 
and transformed into TOP10 competent e. coli (cat. K450001, Thermo Fischer, Waltham, MA). 
Transformants were plated overnight at 37OC; colonies were picked and grown overnight in Lysogeny 
Broth at 37OC. Plasmid DNA was isolated using the Qiagen miniprep kit (cat. 27104, Qiagen, 
Germantown, MD). Plasmids were then sequenced by Eurofins (Lousiville, KY) using stock primers for 
the TOPO plasmid construct. In addition, clones were assayed for PML expression at the protein level by 





Incucyte live-cell Imaging Assay 
Cells were plated with fresh media at 5000 cells per well according to Coulter Counter 
measurements (Beckman Coulter, Brea, CA) in a 96 well plate. These were then placed in the Incucyte 
system (Essen Bioscience, Ann Arbor, MI) to grow under standard growth conditions for seven days. This 
system is essentially a camera mounted in an incubator that takes detailed images of every well. 
Confluency measurements were taken automatically every four hours. Confluency curves were 
generated using IncucyteZoom software (Essen Bioscience, Ann Arbor, MI). 
Microscopy and Image Analysis 
Two microscopes were used in this thesis for capturing images. For section 1, 2, 3 and 5 slides 
were imaged with a Nikon 50i epifluorescence microscope equipped with X-Cite series 120 illuminator 
(EXFO Photonics Solutions, Mississauga, ON, Canada) and appropriate fluorescence excitation/emission 
filters. Grayscale images were captured using Nikon NIS-Elements software version 2.30 and an attached 
Photometrics (Tucson, AZ) CoolSNAP EZ digital camera, pseudo-colored, and merged.    
Images in section 4 were captured using the Tissuegnostics TissueFAXS fluo automated 
fluorescent microscope with accompanying light sources and appropriate fluorescence 
excitation/emission filters. This also included Tissuegnostics branded imaging software. Use of this 
microscope was particularly useful because it provided hundreds of images collected in a consistent 
manner.  
Images from both sources were analyzed in the same manner for number of puncta and number 
of co-localizing puncta. Images were loaded into the imageJ analysis software. Background was 
subtracted using a rolling ball algorithm using the same parameters for all images. This removes auto 
fluorescence of cells. Images were then thresholded for brightness such that all but the faintest puncta 
were included. This is to remove potential background from nonspecific antibody binding. Each channel 
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was thresholded separately and threshold parameters were kept the same for each single stain across 
experiments. The process of thresholding turns the images into binary signals, as once the brightness is 
set the intensity is no longer required for the next step. The images could then be analyzed with a tool in 
imageJ to count the number of events (puncta) across an image which is referred to as a field of view in 
this thesis. For co-localizations between channels involves the same steps except after thresholding the 
images are overlaid. The program identifies overlapping pixels using the co-localization plugin tool for 
imageJ available from: https://imagej.net/Colocalization_Analysis. These events are then counted using 
the same tool for single image counting.  
Immunofluorescence and Western Blotting  
Cells were grown on chambered cell culture slides (# 154534, ThermoFischer Waltham, MA) for 
at least 24 hours and then fixed at room temperature in formalin, neutral buffered, 10% (# HT501128, 
Sigmaaldrich, St. Louis, MO) for 20 minutes followed by a permeability buffer of .5% triton-x (# 9002-93-
1, Sigmaaldrich, St. Louis, MO) in pH 7 PBS for 15 minutes. Slides were then blocked for ten minutes 
using Dako serum free protein block (X090930-2, Agilent, Santa Clara, CA). Primary antibody diluted in 
antibody dilution buffer (251-018, Ventana, Tucson, AZ) was applied for an overnight incubation at 4 oC 
followed by Molecular Probes Alexa-Fluor fluorescently labelled secondary antibodies in PBS-Tween20 
for 30 minutes at room temperature (ThermoFischer, Waltham, MA). Before mounting with ProLong 
Gold antifade reagent (P36931, ThermoFischer) slides were incubated with 4′,6-diamidino-2-
phenylindole (DAPI) for five minutes (ThermoFischer, Waltham, MA). Monoclonal primary antibodies 
used in this study: anti-PML (#sc-966, Santa Cruz, Dallas, TX and, ab200200 Abcam, Eugene, CA), anti-
SP100 (ab167605, Abcam, Eugene, CA), anti-DAXX (#HPA008736, ThermoFischer, Waltham, MA), anti-
phospho-Histone-H2A.X Ser139 (#05-636-I, Millipore, Billerica, MA), anti-TRF2 (NB110-57130, Novus 
Biologics) and anti 53BP1(Novus #NB100-305A-1).  For Western blotting cell pellets were harvested from 
log phase growth cultures and proteins were extracted using RIPA buffer (#9806, Cell Signaling, Danvers, 
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MA) with protease inhibitor cocktail (#04693159001, Roche, Basel, Switzerland). Concentration of 
protein was determined by the BCA assay (#23225, ThermoFischer, Waltham, MA). 30 ug of protein 
were loaded into each lane of a stacking 4-15% Mini-Protean TGX gels (#4561081, BioRad, Hercules, CA). 
An electrical potential of 150V was applied to the gel via a cassette suspended in a bath of 25mM Tris, 
192mM glycine, .1% SDS pH 8.3. A wet transfer onto a nylon membrane (#Z670197, Sigma-Aldrich, St. 
Louis, MO) with transfer buffer 25mM Tris, 192mM glycine and 20% methanol was carried out overnight 
at 10mA. Primary antibody was diluted in TBS-Tween20 with 5% dry nonfat milk and added to the 
membrane for an overnight incubation at 4OC. Membranes were washed three times for 5 min with TBS-
Tween20. HRP conjugated secondary antibodies diluted in TBS-Tween20 with 5% dry nonfat milk were 
incubated with the membrane for one hour at room temperature (#7076S, Cell Signaling, Danvers, MA). 
After three washes with TBS-Tween20 for five minutes ECL substrate (#1705061, BioRad, Hercules, CA) 
with photosensitive film (#3409, Fujifilm, Japan) were used to visualize western blot results according to 
the manufacturer’s instructions.  
Telomere DNA FISH 
Telomere specific fluorescent in situ hybridization was performed using a Cy3 labeled PNA probe 
with the N to C terminus sequence of CCCTAACCCTAACCCTAA. [110]This PNA probe was synthesized by 
Panagene, Daejeon, South Korea. This sequence is complementary to the mammalian telomere repeat 
sequence corresponding to the G-rich strand. For FISH alone, or combined with immunofluorescence, 
chamber slides were fixed and permeabilized as described above followed by steaming in citrate buffer 
for 35 minutes (Vector Laboratories, GA). Slides were then dehydrated stepwise in increasing 
concentrations of ethanol and water, 70%, 90%, 90% for five minutes at a time ending in air drying. The 
FISH probe hybridization mix used consists of 70% formamide, 30% water, 10 mM Tris-HCl pH 7.5. 
Telomere probe was added to the mix for a final concentration of 0.3 ug/ml. Enough of the probe in 
hybridization mix was added to cover the slide followed by a coverslip. Slides were incubated at room 
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temperature for two hours in a humidified chamber and then washed twice for 15 minutes with a PNA 
wash solution of 70% formamide, 30% water, 10 mM Tris-HCl pH 7.5.  Slides were rinsed briefly in PBS 
and stained with DAPI. Prolong Gold anti-fade mounting medium was then applied and slides were 
cover slipped. Immunofluorescence and telomere FISH protocols can be combined on the same slide for 
combination FISH and immunofluorescence. Telomere FISH is first carried out to the PBS rinse step after 
the PNA wash and then the (above) immunofluorescence protocol is followed starting from protein 
blocking until coverslipping.   
Telomere RNA FISH (TERRA) 
TERRA-specific FISH is similar to telomere DNA FISH, except for the use of locked nucleic acid 
probes instead of PNA and there is no denaturation.[111] These also require different hybridization 
conditions to maintain telomeric DNA in its native double-stranded form, so as to avoid undesired probe 
hybridization to telomere DNA species, rather than the desired binding to telomere RNA species 
(TERRA). The TERRA LNA probe sequence 
is:FAM/CCCTA+AC+CCT+A+AC+CCTAACCCT+A+ACCCT+A+ACCCT+A+ACCCT+AA-FAM with FAM being a 
green fluorescent probe label and the + sign indicating the following base as a locked nucleic acid. The 
opposite strand probe is TAM/GGGT+TAGGG+T+TAG+GGTTAGGG+T+TAGGG+T+TAGGG/TAM with TAM 
being a red fluorescent probe label. Both were ordered from Exiqon in Denmark. Cells grown in chamber 
slides were fixed and permeabilized as outlined above. For hybridization, slides were dehydrated 
stepwise as outlined above. The TERRA FISH or opposite strand probe hybridization mix is 2xSSC, 50% 
formamide, .2% BSA, 10 ug yeast tRNA (Thermo FischerAM7119) and 200 nM of probe. The mix is 
incubated on the slide for 1 hour in a humidified chamber at 37 oC. Wash follows with .1x SSC for 15 
minutes at 60 oC then 2x SSC for 5 minutes. Slides are DAPI stained and mounted as outlined above. For 
RNAse treatments 200 ug/ml of RNAse A (#10109142001, Sigma Aldrich) in PBS was applied to the slides 
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before the dehydration step for 30 minutes at 37oC. Denaturation treatments use the citrate steam 
outlined above for telomere DNA FISH before dehydration steps.     
Telomere COFISH 
The telomere-specific chromosome orientation fluorescence in situ hybridization (COFISH) assay 
[112] was performed by first supplementing the media of logarithmically growing cell cultures at 70% 
confluency with 7.5 uM bromodeoxyuridine and 2.5 uM bromodeoxycytidine (B5002 and 
COM448648460, Sigma-Aldrich, St. Louis, MO). 24 hours later the media was exchanged for fresh pre-
warmed media containing 100 ng/ml colcemid (15210040, Thermo Fischer, Waltham, MA). After a two 
hour incubation under normal growth conditions, cells were trypsinized (25300054, Thermo Fischer, 
Waltham, MA) and neutralized with pre-warmed growth media. Cells were centrifuged at 800x g RCF for 
five minutes and washed once with 1x PBS and pelleted again. The pellet was then suspended in 15 ml 
of a hypotonic solution of .07 M KCl and incubated in a water bath at 37oC for 30 minutes. Cells were 
carefully pelleted at 800x g RCF for five minutes. The hypotonic solution was aspirated to 100 ul 
remaining and one and a half volumes of fresh iced fixative solution of 3:1 methanol: glacial acetic acid 
was added (~400 ul) resuspending the pellet. This was incubated on ice for 30 minutes. Cells were 
centrifuged at 800x g RCF for five minutes, placed on ice, supernatant was aspirated, and cells 
suspended in 500 ul of iced fresh fixative. Positively charged microscopy slides (16004-406, Randor, PA, 
VWR) were prepared for metaphases by soaking slides for 30 minutes in a solution of ethanol and .5% 
(v/v) concentrated HCl. Slides were then rinsed in ice water and placed on a moistened stack of paper 
towels. A transfer pipette was used to drop suspended cells onto the slides. After dropping, slides were 
briefly rinsed in fresh iced fixative and placed on a rack to air dry overnight.  
Prepared metaphase slides were rehydrated in PBS and treated with 0.5 mg/ml RNase A (A797C, 
Promega, Madison, WI) in PBS for 20 minutes at 37oC. Slides were rinsed in PBS. Slides were then 
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incubated in 0.5 ug/ml Hoechst 33258 (861405, Sigma Aldrich, St.Louis, MI) 2x SSC for 15 minutes at 
room temperature. Slides were then placed in a shallow tray of 2x SSC and exposed to 365 nm UV light 
for 5.4x103J/m2. Slides were then treated with 10 U/ul exonuclease III in supplied buffer (M0206, New 
England Biolabs, Ipswich, MA) for 30 minutes at 37oC followed by a 5 minute PBS wash and dehydration 
by graded ethanol series. Two telomere specific PNA probes were used for FISH. A Cy3 labelled N to C 
telomere sequence CCCTAACCCTAACCCTAA “TelC” and a FITC labelled N to C telomere sequence 
GGGATTGGGATTGGGATT “TelG”. FISH was then performed according to the procedures outlined above 
with first the TelG probe followed by washes and then the TelC probe followed by washes. Slides were 
incubated with DAPI for 5 minutes before a PBS rinse and coverslipping with Prolong Gold mounting 
solution. Images of individual metaphases were taken manually (see microscopy). Scoring of telomere 
exchanges was carried out by first recording the total number of clearly identifiable and complete sister 
chromatid pairs. Then the fluorescent channels specific to the TelG and TelC probes were overlaid. Each 
identified chromatid pair was scored positive for an exchange if on a single chromatid arm there were 
coincident TelG and TelC signals.  
Terminal restriction fragment (TRF) measurement 
Following an overnight digestion at 37 oC of cell pellets with at least 5 x10^6 cells with 100 ug/ml 
proteinase K (# 3115887001 Sigma-Aldrich) Phenol/chloroform (#7761 Sigma-Aldrich) was used to extract 
high molecular weight genomic DNA from frozen cell pellets of at least 5 x10^6 cells.[59] Genomic DNA 
from the aqueous fraction of the phenol/chloroform extraction was precipitated with 70% ethanol and 
.2 M sodium acetate and then suspended in water. The entire sample of genomic DNA was digested 
with 50 U of MboI (NEB# R0137L) and AluI (NEB# R0147L) overnight at 37 oC. DNA concentration was 
then measured with the Qubit using the HS dsDNA kit according to manufacturer’s instruction (#Q33851 
Thermo-Fischer). Each sample was loaded equally at 2 ug per well of a 1% agarose gel made from TAE 
(#15558026Thermo-Fischer). Gel electrophoresis at 100V for 4 hours was carried out. The gel was 
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bathed with .25N HCl for 30 minutes for depurination following electrophoresis. The gel was then 
denatured with denaturation solution (0.5M NaOH 1.5 M NaCl) for 30 minutes. The gel was then 
neutralized with neutralization solution (2.5 M NaCl, 1.5 M Tris base) for 30 minutes. The gel was then 
bathed in 20x SSC with gentle agitation for 30 minutes. Downward transfer with 20x SSC (#15557036 
ThermoFischer) overnight was used to transfer DNA to a positively charged nylon membrane ( 
#11209299001, Sigma-Aldrich). The membrane was crosslinked to the DNA by UV light using the 
crosslink setting on a Stratalinker which was followed by a 2x SSC wash. A DIG labelled DNA telomere 
repeat (CCCTAA 24bp) probe was then hybridized at 2nM to the membrane using DIG easy hyb 
(#11603558001, Sigma-Aldrich,) overnight at 42 oC in a rolling bottle. The membrane was washed with 
first 2xSSC + 0.1% SDS for 5 minutes at room temperature then .2x SSC + 0.1% SDS for 30 minutes at 50 
oC. The membrane was blocked with 5% milk for 30 minutes. Anti-DIG-AP Fab fragment (#11093274910, 
Sigma-Aldrich) in 5% milk at a 1:10000 dilution was applied to the membrane for 30 minutes at room 
temperature. The DIG easy hyb wash and buffer set (#11585762001, Sigma-Aldrich,) was used to wash 
the membrane for 30 minutes with wash buffer and equilibrate the membrane for detection with 
detection buffer for 5 minutes. CDP-Star-ready-to-use (12041677001, Sigma-Aldrich) was used as 
substrate for chemilluminescence. Images of the membrane were captured using the Chemidoc Imaging 
System from Bio-rad.        
C-circle assay 
Genomic DNA was isolated from frozen cell pellets using the DNAeasy Qiagen kit (#69504) 
according to the manufacturer’s instructions.[66] Using 50 ng of this DNA the phi polymerase reaction 
was carried out. The reaction consists of 10 mM TTP, GTP, ATP, final 1x buffer of included with the phi29 
polymerase, 2 U of phi29 polyermase (#M0269S, NEB) with the thermal cycling program of 30 oC for 8 
hours, 65 oC 20 minutes with a 4 oC hold. This reaction was loaded onto a positively charged nylon 
membrane in a Schleicher & Schuell Minifold-1 dot blot apparatus, according to manufacturer’s 
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directions. The membrane was UV crosslinked with a Stratalinker. A DIG labelled DNA telomere repeat 
(CCCTAA 24bp) probe was then hybridized at 2nM to the membrane using DIG easy hyb (#11603558001, 
Sigma-Aldrich,) overnight at 42 oC in a rolling bottle. The membrane was washed with first 2xSSC + 0.1% 
SDS for 5 minutes at room temperature then .2x SSC + 0.1% SDS for 30 minutes at 50 oC. Membrane was 
blocked with 5% milk for 30 minutes. Anti-DIG-AP Fab fragment (#11093274910, Sigma-Aldrich) in 5% 
milk at a 1:10000 dilution was applied to the membrane for 30 minutes at room temperature. The DIG 
easy hyb wash and buffer set (#11585762001, Sigma-Aldrich,) was used to wash the membrane for 30 
minutes with the wash buffer and equilibrate the membrane for detection with the detection buffer for 
5 minutes. CDP-Star-ready-to-use (12041677001, Sigma-Aldrich) was used as substrate for 
chemilluminescence. Images of the membrane were captured using the Chemidoc Imaging System from 
Bio-rad.        
Telomeric repeat amplification protocol (TRAP) 
Cell pellets of 1x 10^6 were lysed in a 1% NP-40 (#28324B, Thermo-Fischer) lysis solution. Lysis 
solution: 10 mM Tris-HCl pH 8.0, 1 mM MgCl2, EDTA 1 mM, .25mM Sodium deoxycholate, 10% glycerol, 
5 mM NaCl and .1 mM AEBSF (4-(2-aminoethyl)-benzenesulfonyl-sluoride-hydrochlorine) (#A8456, 
Sigma-Aldrich). [61] After 30 minutes on ice, 2500 cell equivalent of this lysate was used in a telomerase-
dependent primer extension assay having a PCR-based readout. The buffer solution contains 200mM 
TrisHCl, 15 mM MgCl2, 630 mM KCl, tween 20 .5% (v/v), 10 mM EGTA.  This buffer contains a primer mix 
and .2 U Taq DNA polymerase and 10mM dNTP. Primer sequences used: Downstream TRAP: 
GCGCGGCTTACCCTTACCCTTACCCTAACC, Upstream TRAP AATCCGTCGAGCAGAGTT, Internal 
standard AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT reverse standard: 
ATCGCTTCTCGGCCTTTT to a final 2uM of each primer. Reaction mix was then thermal cycled with the 
following program: 30 oC for 30 min, heat inactivation at 94 oC for 10 minutes, denatured at 94 oC for 30 s 
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with a 72 oC extension of 45s. The whole reaction was run on a TBE precast acrylamide gel (#4545034 
Novex) containing SYBR green dye for 140 minutes at 200 V and imaged using UV light.     
Telomere Dysfunction Foci (TIF) 
Combined telomere FISH and immunofluorescence for 53BP1 (#NB100-305A-1, Novus) were 
performed as outlined above, and images were captured (see microscopy). [113] Using the image 
analysis program imageJ, as outlined in microscopy, the number of co-localization events between 
telomere FISH and IF for 53BP1 was determined. The number of co-localizations on a per cell basis was 
determined using this program by marking nuclei from the DAPI stain as regions of interest (ROI) and 















Part 1 TERRA 
The telomeres of mammalian cells have a DNA, a protein and an RNA component.[20, 114] The 
mechanism of the ALT pathway could potentially be the result of changes in any or all of these 
components. It is known that the RNA component is in part made up of the non-coding transcription of 
the C-rich strand of the telomere.[21] These telomere transcripts are known as TERRA. In order to 
examine potential changes in TERRA nuclear localization as a result of the presence of ALT, a protocol 
combining aspects of DNA fluorescence in situ hybridization (FISH) and RNA (FISH) had to be adapted for 
use in intact cells.[111] In order to visualize a target under a standard fluorescence microscope a single 
fluorochrome or epitope is not enough, there must be on the order of thousands. Traditional DNA FISH 
uses the double stranded DNA sequence of interest as the basis for the probe. The target sequence for 
such probes must be large, such as those contained in a bacterial artificial chromosome (BAC), resulting 
in probe binding all along the target’s length, providing sufficient signal for chromogenic or fluorescent 
imaging. It is also necessary to denature the target cell sample (such as with boiling, steaming or 
microwaving) to unwind the DNA or otherwise reveal the target sequence for hybridization. In contrast, 
RNA FISH can be performed with much shorter probes because, while DNA targets are only present as 
two copies, RNA has many transcripts per cell to bind. Since RNA is single stranded no denaturation is 
necessary and is actually detrimental since the target sequence is also located in the source DNA and 
will also be detected by the RNA probe. Telomeres are a special case and complicate these procedures. 
The telomere sequence is repetitive and each of the 92 telomeres per cell can be over 10 kb in length. 
The telomere sequence probe takes advantage of this by being 18 bp in length; binding all along the 
repeat sequence it effectively becomes the large probe sequence outlined above. This is problematic for 
RNA FISH because this probe could theoretically hybridize and thereby visualize both RNA and DNA. It 
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becomes necessary then, when examining TERRA, to have a series of controls to make sure only 
telomere RNA is being detected.  
The ALT positive U2OS cell line used in this study had not previously been examined for TERRA 
FISH at the time of the experiment (figure 1-1). Since ALT cells have unique telomere biology, I sought to 
look at changes in TERRA unique to ALT. TERRA is known to consist of UUAGGG repeats. Under native 
conditions no denaturation of DNA was performed so no telomere DNA should be detected. TERRA is a 
shelterin component so it appears as foci distributed throughout the nucleus mirroring the pattern of a 
telomere DNA stain.[19] Thus, for assessing TERRA by RNA FISH, to ensure signals are not actually 
originating from telomere DNA, another slide was treated with RNAse before hybridization. Here, the 
FISH signal was significantly reduced or almost eliminated after RNAse treatment (figure 1-1). 
Denaturation of DNA by steaming serves as a positive control for the hybridization reaction and 
demonstrates the pattern of telomere DNA staining that the TERRA stain mirrors (figure 1-1). To see if 
an ALT cell could have telomere RNA consisting of the opposite telomere strand, a hybridization to 
detect CCCUAA repeats was carried out under native conditions. No signal was detected in this instance, 
and this also implies that telomeric DNA is not significantly denatured and available for hybridization 
under these native hybridization conditions (figure 1-1). A denatured condition was performed to 
confirm that the probe was working as intended by binding its complementary DNA sequence (figure 1-
1). After this protocol was fully working in the lab, a paper concerning a number of aspects of TERRA in 
ALT was published thereby, obviating a number of hypotheses.[107] Another TERRA-related effort 
attempted was development of a TERRA FISH stain in formalin-fixed tissue sections. Unfortunately, we 
concluded that the heating or other chemical exposures performed in creating  paraffin sections 
prevented RNA only detection. Due to these issues, the primary focus of the thesis work was shifted to 




Part 2 Disruption of PML in ALT Positive Cells 
PML has been implicated to be involved in ALT because the large telomere FISH foci that appear 
in cells utilizing the ALT pathway will frequently have co-localizing PML by IF. [69] This Co-incidence of 
the large telomere foci with PML protein are referred to as ALT associated PML bodies (APBs). In spite of 
this designation, the functional connection between the PML protein and the ALT pathway is 
underexplored. The present study seeks to elucidate the nature of this connection by comparing a 
model of the ALT pathway in the presence of PML to a model of the ALT pathway in the absence of PML. 
This involves first establishing stable PML expressing and non-expressing cell lines of identical 
background and second the assessment of ALT pathway activity in these two groups.   
Two adherent cell lines that are commonly used and also maintain telomeres by ALT are the 
human osteosarcoma cell lines U2OS and SAOS2. Both have APBs and are mentioned as having such 
frequently in the literature.[70] An example of these distinctive bodies visible by combined PML IF and 
telomere FISH appears in figure 2-1. In APB, PML can form a ring or donut shape, while the associated 
telomere sequence DNA normally appear as solid puncta surrounded by PML. APBs are distinctive 
because of the close overlap between PML and telomere DNA with the ALT-associated large telomere 
DNA foci occurring in the center of this ring of PML. It would be reasonable then to hypothesize a 
functional connection between PML and telomeres in ALT based on the phenomenon of APBs. The 
CRISPR/Cas9 technology provides the means to efficiently generate the models required for this study. A 
targeting strategy using the double cutter Cas9 was designed (figure 2-2). This version of Cas9 forms 
double strand breaks at the target site as determined by a guide RNA located on the same plasmid that 
contains the Cas9 open reading frame (table 2-1). The specific target site was selected because it is early 
in the PML transcript (exon 2). This exon is common to all known isoforms of the PML protein, thereby 
preventing partial expression of PML through short isoforms. Since it is at the start of the transcript it 
greatly reduces the possibility of expression of a partially functional truncated protein.  
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Cas9 with and without the PML-targeted gRNA was transfected into U2OS and transduced into 
SAOS2. Cas9 and its gRNA are located on the same backbone in both conditions. The samples treated 
without the PML gRNA but with a functional Cas9 serve as empty vector (EV) controls for the influence 
of the process of Cas9 expression itself and subsequent manipulations. Single cell cloning and screening 
for PML expression was carried out for both cell lines. Cloning is important to ensure that populations of 
cells are homogeneous, and no potential contaminating PML expressing cells will influence results. After 
screening, clones were sequenced at the gRNA target site located in the PML gene (table 2-2). The 
mechanism of action of Cas9 is demonstrated in the sequence of PML knockout clones. Cas9 introduced 
insertions and deletions at the target site that result in nonsense mutations thereby preventing PML 
protein expression. A total of three sequence-confirmed U2OS PML KO clones were selected and two 
confirmed SAOS2 KO clones were also generated (table 2-2). SAOS2 proved to be challenging to work 
with as a result of low transfection efficiency and poor cloning efficiency. IF for PML in U2OS knockout 
clones is negative for signal (figure 2-3). IF for PML in SAOS2 knockout clones is also negative for signal 
(figure 2-4). Western blotting for the PML protein is also negative in all KO clones, with GAPDH used as a 
loading control (figure 2-5). PML is challenging to study partly because of the number of isoforms there 
are. Each one could have different functions or localizations. This is reflected in the western blot results. 
A “ladder” of isoforms is present in EV controls. The lack of these isoforms represents additional 
confirmation that these clones are true PML KO lines.  
Part 3 ALT is maintained in the absence of PML 
Having completed the first step of establishing stable PML expressing and non-expressing cell 
lines for comparison (U2OS EV vs U2OS PML KO and SAOS2 EV vs SAOS2 PML KO) it becomes necessary 
then to assess ALT pathway activity in each of these groups in order to complete the modeling strategy 
outlined in the previous section. Assessment of activity is carried out by analyzing several assays for the 
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known characteristics of the ALT pathway. A single metric is insufficient to confirm the presence of the 
ALT pathway.[53, 62, 63, 66, 69, 105]  
Long term culture of the PML knockout lines was carried out to examine the long term effects of 
PML knockout out on cell viability and telomere lengths (table 3-1). Growth rates between parent EV 
and PML KO lines are similar for both U2OS and SAOS2, However, there is variability between the 
knockout clones in their growth rates, in particular SAOS2 KO 2 having a doubling time 20 hours longer 
than SAOS2 KO 1, but this could be explained by clonal variability. Notably, SAOS2 KO 1 has an identical 
doubling time as the parental (table 3-1). All knockout lines have proven capable of continuous long 
term culture over the course of more than two years. Regarding telomere dynamics, the mechanism of 
telomere shortening occurs slowly over time. As mentioned in the introduction, approximately 300 bp 
are lost per telomere, per replication cycle and assuming a 10 kb starting telomere length it would take 
33 population doublings to erode the telomere. Here U2OS cells have reached over 200 calculated 
doublings and SAOS2 over 150 calculated doublings; thus, in both cell lines with PML KO, they have 
greatly exceeded the predicted number of cell divisions beyond which telomere loss would have 
become lethal (table 3-1). To determine the actual telomere length dynamics of knockout clones a 
terminal restriction fragment (TRF) assay was conducted. There are a number of ways to measure 
telomere lengths, but the TRF allows for determination of length and the heterogeneity of lengths 
present within a population. This technique exploits the fact that telomeres do not have any known 
restriction fragment enzymes targeting them. Therefore, if a combination of frequent cutters is used on 
genomic DNA it will theoretically leave only the telomere fragments intact. Once this is done the 
principles behind fragment separation in gel agarose electrophoresis can be relied upon to spread 
telomere lengths down a gel. Combined with Southern blotting, telomere lengths can then be visualized. 
One of the most defining characteristics of ALT is a wide distribution of telomere lengths from very short 
(1kb) to very large (30 kb); visible using this technique. In a telomerase positive cell line telomere 
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lengths are much more similar from chromosome to chromosome, which generates a less 
heterogeneous distribution centered on a restricted range of sizes.  Figure 3-1 is a TRF of side-by-side 
low population doubling and high population doubling (PD) of each of the PML KO clones. EV low and 
high PD are given for U2OS and SAOS2 as well. The distribution of telomere lengths between low and 
high PD is similar for both EV and KO lines (figure 3-1). A signal ranging from above 23 kb to at least 
below the 4.4 kb marker is present in all lanes. If any changes in telomere lengths had occurred, then 
the distribution of sizes would also change. In particular, if telomere maintenance was disrupted by PML 
loss, then significant attrition in telomere lengths across the entire distribution of lengths should have 
occurred over the two years of continuous culture of these cell lines. Therefore, the observation that the 
PML KO cells survive long term culture without evidence of significant losses in telomere length 
distributions strongly imply ongoing ALT in the absence of PML. An investigation into biomarkers of ALT 
activity of PML KO cells follows. 
A widely used indicator of ALT activity is the C-circle assay. ALT cells have been shown to contain 
extrachromosomal strands of telomere DNA sequence termed extrachromosomal telomere repeats 
(ECTR). One such species is a covalently linked circle of partially double stranded telomere DNA, termed 
C-circles. The assay to detect c-circles  involves rolling circle amplification by the processive phi-29 
polymerase from genomic DNA template samples. In C-circles, the C-rich sequence strand of the 
telomere in its circular form is used as the target for amplification, primed by the partial double 
stranded region of the C-circle. What results is a large amount of the G-rich strand telomere DNA 
sequence products which are then detected using dot blotting. Although the amount of C-circles 
present, and thus the amount of reaction product detected in the C-circle assay, varies widely between 
different ALT-positive cell lines, C-circles have been shown to be ALT-specific, thus any positive signal 
measured from this assay is scored as being positive for ALT activity.[66] Genomic DNA isolated from all 
U2OS and SAOS2 cell lines produced a positive signal in the C-circle assay (figure 3-2). This is expected 
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from the U2OS and SAOS2 EV samples. The negative control is SJSA1, an osteosarcoma line which is 
telomerase positive and ALT negative. No C-circle assay signal was detected in this cell line (figure 3-2).  
To ensure no telomeric genomic DNA introduced from the initial template sample used in the reaction is 
detected (false positives), a reaction negative assay was conducted, showing no such false-positive 
signals were detected from genomic DNA (figure 3-2).  
It is believed that the source of the C-circles is the excision product of ongoing telomere 
recombination in ALT. Most telomerase positive cell lines have no or almost no detectable homologous 
recombination at their telomeres.[53] Recombination at the telomeres is measurable by the 
chromosome orientation fluorescent in situ hybridization assay (COFISH; see methods for details). In this 
assay cells are grown for a single cell cycle in the presence of BrdU/C which labels newly synthesized 
DNA strands through incorporation. Metaphases of labeled cells are spread onto a microscope slide. 
Then the slide is treated with UV which creates breaks in the backbone of labelled strands. Nuclease 
treatment follows which results in the degradation of all labeled strands. What remains is the unlabeled 
DNA. A sequential hybridization reaction follows of first a telomere G strand sequence specific probe 
(green) and then a telomere C strand specific probe (red). Since DNA replication is semi-conservative 
these probes should be discrete with each labelling one arm of a chromatid pair. If an exchange has 
occurred or a strand has been translocated through some means through the course of a single cell cycle 
then a mixing of the two probes will occur. This is because the exchange has essentially cut and paste 
the hybridization target from one arm to the other. Figure 3-3 gives an example of the visualization of 
such an exchange.  For each EV and KO cell line, metaphase spreads were generated and probed for 
exchanges. Then on a per metaphase basis the total number of chromatid pairs were recorded and the 
number of chromatid pairs that had an exchange in that metaphase were also recorded. Analysis was 
carried out by considering the fraction of chromatid pairs per metaphase that scored positive for an 
exchange (figure 3-4). For each line, over 1000 chromatid pairs scored. U2OS EV 1 had 10 metaphases 
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scored and all others had over 20 metaphases scored. To get an average population, the U2OS KO data 
were pooled (n> 60 metaphases) and the SAOS2 KO data were likewise pooled (n > 40 metaphases). 
Each of these were then compared against data from their corresponding EV using a t-test. KO of PML in 
U2OS was associated with a significantly increased fraction of sister chromatid pairs scoring positive for 
telomere exchanges, with an average value for EV of 5% (n=10 metaphases) and for KO 18% (n>60 
metaphases) p<.01 (figure 3-4). In SAOS2, PML KO was also associated with a significantly increased 
fraction of chromatid pairs scoring positive for telomere exchanges, with an average value for EV of 42% 
(n>20 metaphases) and for KO of 56% (n > 40 metaphases) p<.05 (figure 3-4). The presence of these 
telomeric exchanges in KO cells is another indication of the preservation of ALT activity following PML 
KO. If exchanges were significantly reduced or eliminated that would argue against the ALT mechanism 
being maintained in these cells.  
ALT is, by definition, an alternate to telomerase as a means of telomere maintenance. A cell 
must not have telomerase activity to be considered ALT-positive. To measure telomerase activity in the 
PML knockouts, the telomerase repeat amplification protocol (TRAP) was carried out. The readout 
indicates a positive signal when a laddering in increments of 6 bp appears after running the reaction out 
on a high resolution polyacrylamide gel. These 6 bp correspond to the 6 bp increments telomerase can 
add to a strand of DNA. Figure 3-3 shows this positive laddering in the telomerase positive cell line PC3. 
No laddering is seen in the EV and KO clones of either U2OS or SAOS2. The RNAse pre-treated sample is 
used to confirm that the laddering is the result of only telomerase activity, as the RNAse will degrade the 
RNA component of telomerase necessary for its activity.   
Part 4 PML and the ALT Body 
The PML protein forms discrete nuclear bodies that are often mentioned to be connected to the 
activities of other nuclear body proteins because these proteins will form co-localizing bodies with PML. 
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These are called “PML body resident proteins”. How often these proteins actually co-localize with PML 
and how critical this localization is to their function is understudied. In order to help understand the 
potential organizing function of PML, the localization of two purported PML resident body proteins was 
examined: SP100 and DAXX. Since these proteins are also reported to be present in APBs, they intersect 
at the normal function of PML and the role of PML in ALT. [54, 104] In order to study this, we asked 
whether PML knockout results in changes in focus formation of these proteins, co-localizations between 
these two proteins, and their relationship to the large ALT-associated telomere foci that form the basis 
of our understanding of the ALT body.  
First the assumptions underlying the above explanation must be tested. The established U2OS 
and SAOS2 cell lines described in the previous sections were utilized. Intact cells grown on chamber 
slides were image analyzed for localization and co-localization events using combined 
immunofluorescence for PML plus DAXX, and PML plus SP100. This dual immunofluorescence approach 
was necessary, as the species specificities of the antibodies used were incompatible in a triple stain. 
Image analysis through the program imageJ was used to avoid bias from manual counting. Important: all 
fields of view are from a 63x objective. Figure 4-1 contains an example staining of SP100 and PML in 
U2OS and SAOS2. Figure 4-2 contains an example staining of DAXX and PML in U2OS and SAOS2. To 
generate table 4-1 the image analysis data from the three U2OS EV clones (n = 8 fields of view each) and 
one SAOS2 EV clone (n= 8 fields of view) were used to generate standard deviations around the mean 
number of nuclear puncta per cell for each cell line. This standard deviation around the mean is the 
range provided in the table. Table 4-1 highlights that these three proteins form nuclear bodies in both 
U2OS and SAOS2 and that there are significant body formations in every cell.  That is to say, you can 
expect bodies as indicated by fluorescent puncta in every cell examined. When the phrase “PML body 
resident protein” is used one would imagine this fits the description of a protein that spends most of its 
time in the PML body. Since in vivo imaging was not an option, it is instead necessary to infer this 
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dynamic from static images. If enough cells and puncta are counted, the prolonged residency of the 
proteins SP100 and DAXX in PML bodies should be reflected in a high percentage of their puncta co-
localizing. Thus in Figure 4-3 the fraction of co-localizing bodies as a fraction of the total bodies of the 
parent is given for each EV cell line (3 clones for U2OS and 1 clone for SAOS2).  SP100 co-localizes with 
PML on average 60% of the time across all cell lines (n= 4), whereas, DAXX co-localizes on average 72% 
of the time with PML. Thus, the majority of nuclear punctae of SP100 and DAXX co-localize with PML 
bodies in the SAOS2 and U2OS EV control clones.. 
Next, having confirmed a link between PML and the proteins SP100 and DAXX, the relationship 
between SP100 and DAXX was examined. This was also examined in the context of PML status to see if 
any relationship between SP100 and DAXX also has a dependency on PML. Figure 4-4 demonstrates in 
U2OS EV that there are co-localizations between SP100 and DAXX (PML was the species limiting 
antibody factor). The figure also demonstrates that there are co-localizations in the absence of PML as 
well. Figure 4-5 demonstrates a similar relationship in SAOS2. In order to account for clone to clone 
variation in total expression levels in the two proteins, or potential changes in expression as a result of 
PML status, a denaturing western blot was performed on whole cell lysates with equal amounts of 
protein loaded for each of the cell lines in question (figure 4-6). The major isoform of SP100 has a kDa of 
54 but it runs anomalously at 100 kDa. This is why it is named SP”100”. The doublet could potentially be 
another isoform as there are six ranging from 50 kDa to 100 kDa. This staining pattern is consistent with 
the antibody manufacturer’s example blot, and both bands were considered when estimating total 
SP100 protein levels. DAXX runs as a single band at 120 kDa, consistent with the manufacturers example 
blot. GAPDH serves as a loading control at 40 kDa (figure 4-6). Densitometry analysis performed on the 
blot is outlined in the next four figures. These results have been corrected for amounts of total protein 
loaded by GAPDH signal and expressed relative to the first EV clone of either U2OS or SAOS2, as 
indicated. Average adjusted relative levels of SP100 are unchanged in U2OS after PML loss (figure 4-7 t-
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test, n=3 each condition). Average adjusted relative levels of SP100 are also similar in SAOS2 after PML 
loss (fig. 4-8). Average adjusted relative levels of DAXX are slightly, but significantly, less (15% reduction) 
in U2OS after PML loss (figure 4-9 t-test p<.0005, n=3 each condition). Average adjusted relative levels 
of DAXX are similar in SAOS2 after PML loss (figure 4-10).  
With SP100 and DAXX co-stain and total protein levels established, the localization and co-
localizations in terms of average puncta per cell of SP100 and DAXX were determined across all cell lines. 
Image analysis was carried out on U2OS for three separate EV and KO cell lines with 8 fields of view for 
each EV line and 8 fields of view for each KO line with a minimum 300 nuclei analyzed (figure 4-11). This 
was also carried out for SAOS2 with 8 fields of view for the EV and greater than 8 fields of view for the 
two KO lines with minimum 300 nuclei analyzed each (figure 4-12). These data are summarized in figure 
4-13 in which samples were grouped by cell line and then PML status. The total fields of view for U2OS 
WT is the sum of the fields of view for the three EV control cell lines n=24. This was repeated for the 
other cell lines (figure 4-12). U2OS KO PML has n=24 fields of view, SAOS2 EV 1 has n = 8 and SAOS2 KO 
has n =16. In U2OS, the average number of SP100 puncta per cell was not significantly different between 
WT and KO. In contrast, the DAXX puncta and the corresponding co-localizations with SP100 are 
significantly decreased by fivefold and tenfold, respectively (t-test p<.0005) in the PML KO compared to 
EV (figure 4-12). In SAOS2 there is a significant increase in SP100 average puncta per cell from 4 in WT to 
5.9 in PML KO (figure 4-12 t-test p<.0005). No significant change was seen in SAOS2 average DAXX 
puncta per cell between KO and EV (figure 4-12). As with U2OS, a significant decrease in SP100 and 
DAXX co-localizations was also seen in SOAS2 PML KO compared to SAOS2 WT (figure 4-12). The 
principal result then from both U2OS and SAOS2 is a decrease in the average number of co-localizations 
between SP100 and DAXX as a result of PML loss. This however can be difficult to interpret, as the drop 
in total puncta of either protein could influence the total number of possible co-localizations. To account 
for this, the data were reanalyzed as a fraction of the total number of nuclear bodies of either SP100 or 
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DAXX. Figure 4-14 details the fraction of SP100 puncta that co-localize with DAXX in terms of total SP100 
punctae for either cell line using data from figure 4-13. A significant decrease in the fraction co-localizing 
was seen for both cell lines in the PML KO with a decrease of 85% in U2OS and a decrease of 58% in 
SAOS2(t-test p<.0005). Figure 4-15 details a similar manipulation but for DAXX, and it too has a 
significant decrease in fraction co-localizing with SP100 -  with a decrease of 23% for U2OS and a 
decrease of 62% for SAOS2 (t-test p<.0005). These results indicate then that even when correcting for 
the total number of bodies available for co-localization there is a significant drop in SP100 and DAXX 
body co-localizations in response to loss of PML. 
PML is connected to ALT primarily through its co-localizations with the large, ultra-bright 
telomere DNA foci seen in a subset of cells in ALT-positive cell lines and human tumors. These large 
telomere foci are often referred to as APBs, since they often (although not always) co-localize with PML. 
In the course of investigating ALT positive cell lines it becomes clear that the number and size of foci can 
vary drastically between cell lines. A comparison of the telomere FISH stain between U2OS and SAOS2 
exemplifies this variability (figure 4-16). The telomere staining pattern in U2OS is consistent from cell to 
cell and large outlying ultra-bright telomere foci are difficult to distinguish at low power (figure 4-16). 
Additionally, U2OS has significant chromosomal telomere signals, making it difficult to determine on the 
cellular level which signal is from a chromosome and which is from the APB foci, which are presumed to 
be largely or exclusively composed of extrachromosomal telomeric sequence DNA. APBs could also 
consist of some mix of these two that may be constantly changing. SAOS2, in contrast to U2OS, fits the 
classic description of ALT telomere FISH. Here, most cells have a low baseline of telomere staining but 
some cells have distinct nuclear foci far in excess of average telomere DNA content (figure 4-16). 
Looking at a field of SAOS2 cells, as in figure 4-16, these large, ultra-bright foci are readily apparent 
(asterisk indicated). One of the significant challenges in studying APBs is how to properly identify them. 
This is also, in part, why this thesis came about. To avoid these confounding factors, studies on ALT body 
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formation were carried out in only SAOS2. Additionally, a high threshold of brightness for image analysis 
was established for telomere FISH signals in SAOS2. This high threshold should significantly exclude 
chromosomal telomere DNA signals and focus analysis only on these archetypical APBs. To confirm the 
assumptions behind calling these large telomere foci APBs, a combined telomere FISH and 
immunofluorescence for PML experiment was carried out with SAOS2 EV (figure 4-17). Two different 
antibodies against PML were employed to examine their potential use in experiments and to check for 
consistency of results. Both antibodies resulted in 20% of total PML puncta as co-localizing with large 
telomere foci in SAOS2 (figure 4-17 n= 8 fields of view FOV). A non-significant difference was apparent in 
the two antibodies for the fraction of large telomere foci co-localizing with PML ( figure 4-17t-test not 
significant n= 8 FOV). In this case, the rabbit-derived PML antibody used gave 85% of large telomere foci 
as co-localizing with PML, while the mouse-derived PML antibody gave a 72% rate of co-localization 
between the two (figure 4-17 n= 8 FOV for both).  
Having investigated the connection of SP100 and DAXX through PML, and the connection of PML 
to the large telomere foci characteristic of APBs, the connection between SP100, DAXX and large 
telomere foci was examined. SP100 and DAXX do co-localize with large telomere foci, both with and 
without PML in SAOS2 (figure 4-18). Next was asked if there was a change in the association of these 
bodies as a result of PML loss, that is, can APBs still form without PML; SP100 and DAXX co-localizing 
with large telomere foci being used here as a measure of ALT body formation. By definition, APBs rely on 
PML for their identification, but without PML co-localizations between ALT-associated telomere DNA 
foci, SP100 plus DAXX, this is the next best indicator that these structures are still able to form, even in 
the absence of PML. Telomere FISH and SP100 DAXX IF were performed on SAOS2 EV and SAOS2 PML 
KO 1 and 2. Image analysis was carried out for puncta co-localizations, with telomere thresholding as 
outline above so as to only assess the bright ALT-associated nuclear telomere DNA foci. (Figure 4-19, EV 
n= 8 FOV, KO1 n=12 FOV, KO2 n=16 FOV total at least 300 nuclei for each). Results indicate ALT-
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associated large telomere foci are still present on a PML KO background and foci have co-localizations 
with SP100 and DAXX. The total EV was then compared to the total KO populations (Figure 4-20). We 
found that the number of large telomere foci do not change as a result of PML loss in SAOS2 ( figure 4-
20 t-test n.s. EV n=8 FOV, KO n=28 FOV). The number of co-localizations between telomere foci and 
SP100 was decreased from .9 to .4 puncta per cell, a 55% decrease, and the number of co-localizations 
between telomere foci and DAXX was also decreased from .9 to .4 puncta per cell, again, a 55% decrease 
(figure 4-20). The triple co-localization between telomere foci, SP100 and DAXX decreased from .8 
puncta per cell to .1 puncta per cell, an 85% decrease (figure 4-20 t.test p<.0005 each comparison EV 
n=8 FOV, KO n=28 FOV). These results indicate that the telomere DNA ALT bodies still form without 
PML, although at a significantly reduced frequency. They also indicate that PML loss has reduced the 
association of SP100 and DAXX to the ALT body.  
Part 5 PML and the DNA damage response (DDR) 
Potential perturbations in the DDR as a result of PML loss were seen in the increased strand 
exchanges at telomeres (figure 3-3). PML is connected to ALT which is itself connected to the DDR 
through its postulated reliance on the mechanism of homologous recombination.[63] Because of this, 
and to examine any potential telomere dysfunction, an analysis for telomere dysfunction induced foci 
(TIF) was performed on the EV, PML KO cell lines outlined previously. TIFs are identified by any co-
localizations of a DDR marker, typically yH2AX or 53BP1, with telomeres.[115] Combined telomere FISH 
and IF for 53BP1 is demonstrated in figure 5-1. Images were captured to cover at least 200 nuclei for 
each of the Cas9 clones and images were analyzed for puncta. Average TIFs per cell indicates a wide 
range of cell scores from a large number of cells with no TIFs and some with many (figure 5-2). Another 
way to examine TIFs is to consider them as a marker of cells experiencing significant telomere 
dysfunction. This involves looking only at cells that have multiple TIFs, and not just potentially incidental 
or insignificant TIFs.[7] Figure 5-3 uses 5 TIFs as the cut off and compares the total EV and KO 
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populations for either U2OS or SAOS2. By this metric, there is no significant increase in telomere 
dysfunction as a result of PML loss in U2OS (figure 5-3 t-test not significant n= 600 nuclei EV or KO). An 
















 PML specific gRNA primers used with included cloning overhangs. PML sequence in red. 
Primer Target Site on Transcript Sequence 
PML Exon 2 Sense 507-485 CACCGCAATCTGCCGGTACACCGAC 
 




Table 2-2  
PML gene sequencing in empty vector controls (EV) and PML knockout (KO) cells. CRISPR/cas9 treatment introduced insertions and deletions at 
the targeted cut site leading to PML knockouts in the ALT utilizing cell lines U2-OS and SAOS2. The type of mutation leading to PML disruption is 
also provided. Guide sequences highlighted in red.  





U2OS EV n/a 1  Detected Seq TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG   
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG   
U2OS KO1 Deletion  
1 bp 
2  Detected Seq TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTC-GTGTACCGGCAGATTGTGGATGCGCAGG   
             ||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG   
U2OS KO1 Deletion  
13 bp 
2  Detected Seq TCTTTTTCGAGAGTCTGCA-------------GTGTACCGGCAGATTGTGGATGCGCAGG 
             |||||||||||||||||||             |||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG   
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U2OS KO2 Deletion 
1 bp 
2 Detected Seq TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTC-GTGTACCGGCAGATTGTGGATGCGCAGG 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG 
U2OS KO2 Deletion 
5 bp 
2 Detected Seq TCTTTTTCGAGAGTCTGCAGCGGCGCCT-----TGTACCGGCAGATTGTGGATGCGCAGG 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG 
U2OS KO3 Insertion 
1 bp 
1 Detected Seq TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGGTGTACCGGCAGATTGTGGATGCGCAGG   
             ||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTC-GGTGTACCGGCAGATTGTGGATGCGCAGG   
SAOS2 EV  1 Detected Seq TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG   
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG   
SAOS2 KO1 Deletion 
 87 bp 
2 Detected Seq TCTTTTTCGAGAGTCTGCAGCG------------87bp deletion-------------   
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG   




2 Detected Seq TCTTTTTCGAGAGTCTGCAGCGAGCAGCTCCTC--TG--C-GCCA-AGTGCTTCGAGGCACAC- 
             |||||||||||||||||||||| ||  ||  ||  ||  | | || | || |  || || ||                                                
Refseq PML   TCTTTTTCGAGAGTCTGCAGCG-GCGCCTG-TCGGTGTACCGGCAGATTG-TG-GATGCGCAGG 
SAOS2 KO2 Deletion 
37 bp 
2 Detected Seq TCTTTTTCGAGAGTCTGCAGCGGC----------(37 bp deletion)----------  
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Refseq PML   TCTTTTTCGAGAGTCTGCAGCGGCGCCTGTCGGTGTACCGGCAGATTGTGGATGCGCAGG 
 




2 Detected Seq TCTTTTTCGAGAGTCTGCAGCGAGCAGCTCCTC--TG--C-GCCA-AGTGCTTCGAGGCACAC- 
             |||||||||||||||||||||| ||  ||  ||  ||  | | || | || |  || || ||   






Table 3-1  
The ALT cell lines U2OS and SAOS2 are viable, grow at rates similar to parental lines. Average growth rates are given for logarithmic growth 
phase and determined from confluency data obtained from Incucyte monitoring (see methods for details). 
Cell line Growth rate (doubling time in hours) Maximum population doublings 
U2OS Parental Line  35 - 
U2OS EV clone 1 30 700 
U2OS PML knockout clone 1 30 350 
U2OS PML knockout clone 2 35 400 
U2OS PML knockout clone 3 35 200 
SAOS2 Parental  50 - 
SAOS2 EV clone 1 50 150 
SAOS2 PML knockout clone 1 50 150 
SAOS2 PML knockout clone 2 70 150 
 
Table 4-1 
The proteins PML, SP100 and DAXX are nuclear proteins that form numerous nuclear bodies that appear as nuclear puncta when visualized with 
immunofluorescence. The table indicates puncta per cell for the cell lines U2-OS (data from three separate U2-OS clonal cell lines n = 8 fields of 
view covering greater than 300 nuclei) and SAOS2 (one clonal population n = 8 fields of view covering greater than 300 nuclei) as one standard 
deviation from the mean.   
Protein U2OS SAOS2 
PML 11-18 2-5 
SP100 8-17 3-7 








Figure S1-1 See next page for description. 
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Figure S1-1 The end replication problem. Replication occurs from a template read in the 3’-5’ DNA sequence direction and synthesized in the 5’-
3’ DNA sequence direction. An RNA primer is required for DNA polymerases to begin the catalysis of DNA base addition.  As replication proceeds 
through unwinding of the template duplex DNA (referred to as a replication fork) the restriction in reading and synthesis direction results in one 
strand being replicated continuously (leading strand) and one strand being replicated discontinuously (lagging strand). The lagging strand has 
many fragments of replicated DNA referred to as Okasaki fragments. The RNA primer is degraded and the Okasaki fragments are extended such 
that all fragments can be ligated and the replicated strand is continuous. However, at telomere of the lagging strand there is no proximal Okasaki 
fragments that can be extended to fully complete replication at the terminus. This results in a protruding G rich telomere repeat sequence 
(AATGGG). To prevent loss of sequence the enzyme telomerase adds telomere repeats to the G-rich extension. This allows for the replication of 
additional complimentary sequence. A gap from the removed primer is still present (3’ overhang) but the net length of the telomere is retained. 










               G Strand Telomere Probe           C strand telomere probe 
Figure S2-1 Method for detecting homologous recombination within telomeres. (A) Mitotic cells are collected after culture in bromo-substituted 
nucleotides for a single cell cycle. Metaphases are prepared on microscope slides, and are then  stained with the DNA-binding fluorescent dye 
Hoechst 33258. Exposure to UV light nicks the newly-replicated strand, and exonuclease III digests it. The process leaves behind the two parental 
strands that are now located on their respective sister chromatids. A single stranded telomere sequence probe hybridizes to complementary 
telomeric DNA on one chromatid of each chromosome arm producing a signal for each arm - either the G-strand (green) or its complement the 
C-stand (red) (B) The expected effect of a telomeric sister chromatid exchange (T-SCE) within telomeric DNA is to split the hybridization signal 








Figure S2-2 Formation of C-circles via homologous recombination. Each arrow represents a telomere repeat along a single chromosome. Repeats 
are capable of being aligned for homologous recombination because their sequence is identical. Intra telomere recombination can result in 
excision of telomere repeats by circularization. Telomere circles can potentially be used as a substrate for further homologous recombination at 




Figure S2-3 The C-circle assay.  Genomic DNA is isolated from a sample that potentially contains c-circles. A small amount of this genomic DNA 
(here 50ng of DNA is used) is then combined with phi29 polymerase in reaction buffer and three of the four DNA nucleotides. C is excluded from 
the reaction to increase specificity because there are no C bases in the TTAGGG repeat being amplified. The product is the G-rich strand 
complementary to the c-circle CCCTAA repeat sequence. Rolling circle amplification (RCA) is primed by a naturally present fragment of telomere 
G strand annealed to the c-circle. RCA refers to the ability of phi29 to continuously traverse the template circle to produce a significant length of 
complementary sequence. The reaction products are then loaded onto a membrane and visualized with a labelled CCCTAA repeat probe. TE-85 
is an ALT negative cell line. IIIFC/c is an ALT positive cell line. A phi29 negative reaction is included to ensure no detection of telomere sequence 




Figure S3-1 The PML gene and protein isoforms. The human promyelocytic leukemia (PML) gene is located on chromosome 15q22. a) It spans 
~53,000 bases and contains nine exons. b) Alternative splicing of the C terminus generates different isoforms. All PML isoforms contain the first 
three exons, which encode the RBCC/TRIM motif. This is a tripartite structure that contains a zinc-finger called the RING motif (R), two additional 
zinc-finger motifs (B-boxes; B) and a coiled-coil domain (CC)The RBCC motif promotes homo-multimerization and the formation of 




























































































































                  
                  
                  
                  
                  
                  
                   




The ALT pathway refers to the means by which 5-15% of cancers maintain their telomere 
lengths without discernible telomerase activity.[50] Finding a means to halt ALT activity presents an 
opportunity to potentially cure these cancers as all dividing cells need to maintain their telomeres. The 
probability of finding a cure will only increase as our understanding of ALT increases. What is known 
now about ALT is based on the examination of tumors that do not have telomerase activity. These 
observations allow us to list shared characteristics of cells with ALT but the causation of ALT remains 
unknown. The characteristics explored in this study include: no telomerase activity, heterogeneous 
telomere lengths, presence of extra chromosomal telomere c-circles, homologous recombination at 
telomeres, and the presence of APBs.[51, 54, 62, 63, 69] Within these correlated factors there may be 
causal factors for ALT. The examination of TERRA was in part motivated by the need to discover as many 
ALT associated characteristics as possible. At the time TERRA had not been characterized in ALT cells. To 
discern if the PML component of the APB is just correlated to ALT versus being required, the PML 
protein was eliminated from ALT cells and ALT activity was then assessed in these knockout cells. There 
are several questions that this study also sought to elucidate. Do human cells survive without the PML 
protein? Can ALT cells survive without PML but not maintain their telomeres? Are some characteristics 
of ALT dependent on the presence of PML? Are they modified by PML? Beyond this question of 
requirement for the ALT pathway there are data to describe the formation of ALT associated nuclear 
bodies. Is there TERRA in these ALT bodies? Are the large telomere foci still forming? Are there 
components associated with the APB that are constant and could be candidates for further study? Lastly 
this study presents an opportunity to learn more about the PML protein. What role is PML playing in 
nuclear trafficking? It is known for forming nuclear bodies but there is much to be learned regarding the 




Part 1 TERRA 
The telomeres of mammalian cells have a DNA, a protein and an RNA component.[20, 114] It is 
known that the RNA component is in part made up of the non-coding transcription of the C-rich strand 
of the telomere.[21] FISH for TERRA species in a normal human cell and in the HeLa cell line produces 
signals that mirror the pattern of a telomere DNA FISH.[26] Combined IF-FISH for TRF2 and TERRA 
indicates this pattern is the result of TERRA binding to telomere sites.[19] Since TERRA is FISH visible and 
the large telomere foci common to cells utilizing ALT are also FISH visible, it provided an opportunity to 
examine if TERRA is localized to these foci. Additionally, ALT cells could have changes in TERRA patterns 
versus what has been previously observed. TERRA in the U2OS cell line appears in a pattern and amount 
consistent with published findings on TERRA.[20, 107] There was no CCCTAA repeat RNA detected which 
means that no telomere transcripts are being generated from the G strand telomere sequence. While 
simple in nature these conclusions have significance from what they exclude as possibilities for telomere 
RNA biology in ALT cells. Chromosomal telomeres in ALT cells have significant spontaneous telomere 
dysfunction and DNA damage signaling.[115] Normal TERRA functions as a part of the shelterin complex 
and disruption in its function could partly explain this persistent DNA damage response signaling in ALT 
cells.[97, 115] Potential abnormalities in TERRA in ALT that could be tested could include changes in 
localization or in TERRA levels relative to telomere DNA signals. Assessing whether TERRA was in APBs 
was the continuation in this line of reasoning. As with many good ideas, while these studies were 
underway, another group published work on TERRA in ALT confirming that TERRA is indeed found in 
APBs, and TERRA levels relative to telomere DNA content is 1000 times more than in ALT cells than in 
telomerase positive cell lines.[107] On the subject of opposite strand transcription of telomeres, or anti-
TERRA, if it had been found then it would have been unique to ALT, as it has not been observed in non-
ALT human cells.[21] The finding of alti-TERRA would imply that hybridization of alti-TERRA to TERRA 
could take place, thereby potentially pulling TERRA away from the shelterin complex, contributing to 
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telomere dysfunction. TERRA is still a promising area of research with many unanswered questions 
having implications for telomere biology. In terms of ALT, why is TERRA over-expressed? Is this one of 
the steps in the development of ALT? Why is TERRA in APBs?  One particularly interesting area is the 
development of a TERRA stain for paraformaldehyde-fixed paraffin embedded tissues. If telomere 
lengths are important in identifying and subtyping cancer, then the TERRA RNA component may turn out 
to be critical as well. 
Part 2 PML and ALT  
The principal connection between the PML protein and the ALT pathway is the APB.[69] What 
establishes the significance of the APB to the ALT pathway is that these bodies contain large amounts of 
telomere sequences. ALT is a telomere maintenance mechanism believed to be based on homologous 
recombination (HR).[63] In support of this is the observation of the localization of several DNA repair 
proteins e.g. RAD51, BRCA1/2, RPA to the APB and knockout of the components of HR result in a loss of 
viability in ALT cells.[54, 55, 58, 101, 112] HR is classically a DNA repair pathway and not necessarily a 
replicative process[117, 118]. It stands to reason then that these foci are potential sources of telomere 
sequence that are important for the ALT mechanism. PML is frequently observed at these foci even 
going so far as to give them a designation.[54] Just how often within or between ALT utilizing tissues 
APBs form has not been studied extensively. It is important to also note that neither the requirement of 
large telomere foci nor the PML protein for the ALT pathway has been established. This presents an 
excellent opportunity for examination by the current study.  
As the results presented in this thesis show, human cell lines are viable without the PML protein. 
A similar conclusion was drawn for mice as there is a PML knockout mouse model.[71] These findings 
seem surprising, given the many essential pathways that PML protein has been thought to play a role 
in.[70-72, 75, 87, 94, 96, 106, 119] It is important to make note of this because it can help explain why 
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there are no PML connected genetic diseases. Promyelocytic leukemia is a disease connected to PML 
but it is not believed to be driven by functional loss of PML.[95] Some other pathway must be redundant 
with that of PML or its loss can be compensated for such as with transcriptional changes. Another 
possibility is that PML may interact with many proteins but have only a slight influence on each, thereby 
reducing the impact of its loss. PML is an interferon response gene, and if viewed through the lens of 
immunology this pattern seems more reasonable. Many components of the mouse immune system can 
be knocked out in a stable viable mouse model [120]. Another possibility is that PML is required for the 
viability of normal human cells, but the cancer-derived cell lines used here have so much disruption in 
their genome that they no longer depend on intact PML. PML is intimately linked to the TP53 pathway, 
and that pathway is knocked out in at least half of cancers.[119] TP53 status may be playing a role in the 
present study as well. The U2OS cell line is wild type for TP53 and SAOS2 is a knockout for TP53 and it 
has been observed to have a significant impact on DNA damage signaling in these cell lines.[115] This 
may help explain the recorded differences in this study in telomere recombination or TIF formation 
between the two cell lines. Lastly on a similar note to the TP53 pathway, the PML knockout phenotype 
may be more apparent in stress induction experiments. It is intimately linked to the SUMO ubiquitin 
pathway which are known to respond to stress.[77, 91, 92, 121, 122] Thus, in order to fully investigate 
the impact of PML loss on general cellular viability further work is needed.   
As shown in this thesis, cancer-derived ALT cell lines are viable without the PML protein.  
Whatever role it had, if it had any, in the pathogenesis of these ALT-utilizing cancers, PML is either no 
longer necessary, or is able to be compensated for at this snapshot in time of cancer.  The results in this 
thesis also indicate that PML is not absolutely required for multiple ALT characteristics (putative ALT 
biomarkers) that are used to identify a cell as ALT-positive. Notably, no single assay or analysis is enough 
to give a definitive answer as to whether or not a cell, or cell population, is ALT-positive.[123] Experts in 
the field may have their favorite biomarker to identify ALT, but ALT is functionally defined:  ALT-positive 
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cells maintain their telomeres in the absence of telomerase by fundamentally altering their telomere 
biology.[58] Biomarkers that have been associated with ALT include; telomere recombination, telomere 
c-circles, extreme telomere length heterogeneity and comparatively giant masses of telomere RNA and 
DNA sequence in discrete foci within their nucleus. All of this is present in PML expressionless ALT cells. 
In keeping with the maintenance of ALT features, PML knockouts maintain their telomere lengths in the 
long term and do not have a net increase in telomere dysfunction as measured by TIFs. The work 
presented here, by complete deletion of PML definitively show that PML is not required for 
maintenance of pre-existing ALT in human cancer-derived cell lines. 
The data generated in this thesis support the existing designation of SP100 and DAXX as PML 
body resident proteins. In both SAOS2 and U2OS, across an asynchronously grown population of cells, 
SP100 and DAXX spend more time in PML bodies than out of them, as indicated by co-localization 
studies. It would be reasonable then to believe that there could be functional connections between 
these 3 proteins. The data is somewhat inconsistent between the two cell lines in terms of the total 
puncta and protein levels. Despite clone-to-clone and cell line-to-cell line variations observed in the cells 
studied here, PML does act to increase interactions between SP100 and DAXX which is consistent in 
both cell lines. PML could then be acting as a regulator of intra-nuclear trafficking of these proteins. 
Here, there are a number of possible mechanisms of action. PML could be acting like a storage depot for 
nuclear proteins, or at least SP100 and DAXX, although it is not possible to draw conclusions on the 
purpose of such a storage site from the presently available data. It could be a nuclear vesicle for 
transport of these proteins to specific sites in the nucleus such as sites of DNA damage. The data is a 
fixed snapshot and this would require further investigation in live cells. The drop in co-localizations of 
SP100 and DAXX could be explained also by a decrease in the residency time of these two proteins at a 
specific site, without PML acting to “hold” proteins there. The concept of PML acting as a mediator of 
interactions between proteins provides a link to our understanding of the nature of the APB. 
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 The data obtained here are consistent with previous observations of APBs for the SAOS2 cell 
line.[69] These observations are critical to understanding the significance of this thesis. Time and again 
the large telomere foci in different ALT cell lines have been presumed to be synonymous with the APB. 
This assumption stems from the frequent co-localizations of PML with these foci. A dogmatic approach 
to APBs is potentially harmful for studying ALT, because even in a cell line where 85% of large telomere 
foci have PML there are still 15% of them that do not. As shown in this thesis, these large telomere foci 
are still present even in complete PML knockouts. What does this mean then for discerning the role of 
PML in ALT? Could it be that PML is not required for ALT because APBs or ALT bodies still form without 
it? This would be consistent with the theory that these large foci are the site of the mechanism of action 
of ALT but this has not been conclusively proven.[103] SP100 and DAXX each still co-localize with large 
telomere foci and even all three occur together without PML. The theorized role of PML as a mediator of 
nuclear traffic remains consistent when examining ALT bodies. PML loss decreases the number of times 
SP100 and DAXX interact but also the number of times these proteins interact with large telomere foci. 
The continued interactions of these proteins after PML loss with the foci may have other implications for 
ALT.  Mutations in DAXX have been linked to the presence of ALT in tumors and it may be possible that 
mutations in SP100 will also be significantly linked to occurrence of ALT.[46, 50] One particular 
observation worth examining is the determination of ALT activity by the c-circle assay. The results here 
demonstrate continued ALT activity in all clones, but there is noticeable variability between EV and PML 
KOs. C-circle levels have been used to quantify  ALT “activity”.[66] There is also the increase in 
homologous recombination in PML KO. Are these two observations linked? C-circles may be the excision 
product of homologous recombination. There is also the alternate viewpoint that PML is acting to inhibit 




Although PML is not required for the maintenance of ALT, this does not mean that it may not be 
a useful therapeutic target in ALT-positive cancers. Rescue experiments on PML KO clones could help 
determine the quantity of change in the characteristics of ALT by reducing clonal variability. The 
generalizability of the findings regarding the loss of PML and phenotypes such as focus formation and 
co-localizations of PML body resident proteins, such as SP100 and DAXX, could be furthered by 
investigating telomerase-positive/ALT-negative cancers using Cas9 against PML. Clinical ALT-positive 
cancer samples can be examined for PML expression levels and co-localizations between PML and PML-
interacting/PML body resident proteins. Discerning the impact of PML on extrachromosomal telomere 
DNA versus chromosomal telomere DNA could further our understanding of just what is in an APB and 
give possible clues to its function (if one indeed exists) in ALT-positive cells. Reintroduction of PML 
labelled with GFP could allow for in vivo imaging of the formation of ALT bodies. 
A number of significant findings that advance our understanding of the ALT phenomenon are 
presented in this thesis. TERRA localization in U2OS occurs in a pattern consistent with its previously 
described residency at telomere DNA sequences. The PML protein is not required for cell growth and 
the maintenance of telomere lengths in cells utilizing the ALT pathway. PML is also not required for the 
ALT biomarkers of telomere recombination, c-circles and does not reactivate telomerase. This work also 
makes several conclusions that may redefine the way we describe the APB. Large telomere foci do not 
require PML to form and these foci can still co-localize with the PML body resident proteins SP100 and 
DAXX. Does this imply that we should refer to these as just ALT bodies and drop the PML designation? 
Just what is required then for the definition of an ALT body? Are they even necessary? This work also 
informs our understanding of PML body resident proteins. PML is not required for these proteins to 
form nuclear bodies but it does however change their frequency. PML is therefore important for these 
proteins localization which may also impact the function of these proteins. Interestingly their overall 
expression is almost unaffected which leads to wonder of the impact of their diffusion in the cell. 
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Telomere dysfunction is also not increased in PML knockouts so PML may not be important for telomere 
stability. Both PML and ALT are complex in function and this study raises more questions than answers 
but this study could represent a blueprint for determination of the factors that are necessary for ALT. 
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